Clinical Trial Update: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients

View source ↗

Summary

A clinical trial evaluating whether a plasma protein profile can predict metastatic relapse in patients with triple-negative breast cancer; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Centre Jean Perrin | Conditions: Triple Negative Breast Cancer | Status: ACTIVE_NOT_RECRUITING